DFTX
#1279
Definium Therapeutics, Inc. - Common Shares
41.5 1 USD
-0.05%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-5.27%
Changement Mensuel
-1.17%
Evolution sur 6 mois
+147.67%
Changement Annuel
+174.72%
Clôture Précédente
43.8 2
Open
41.2 0
Low
41.1 1
High
41.6 3
Volume
316
Financials
- Market Capitalization 5.58 B
- Employee 106
- Founded 2010
- CEO Robert Barrow
- Website www.definiumtx.com
- Headquarter British Columbia, Canada
- FIGI BBG00F13HYQ7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1254 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 59.90 USD | -3.28% | -2.54% | -8.30% | +46.85% | 5.80 B USD | ||
| 1278 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 280.21 USD | -1.51% | -3.04% | -4.89% | +49.75% | 5.59 B USD | ||
| 1284 |  CRSP CRISPR Therapeutics AG - Common Shares | 57.44 USD | -3.25% | -4.90% | +21.13% | +8.44% | 5.55 B USD | ||
| 1348 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 29.19 USD | -1.82% | -0.58% | +11.75% | +11.45% | 5.03 B USD |